Poison Pill Anti-Takeover Defense

Omnicare files suit against PharMerica

Omnicare files suit against PharMerica

Omnicare has filed a lawsuit in hopes of making PharMerica accept a $440 million purchase offer and halt a poison pill anti-takeover defense.